BioSpace News Archive

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the virtual 10 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 5:00 p.m. ET.

GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41 st Annual Health Care Conference.

Aeterna Zentaris Inc. announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 20,509,746 common shares of Aeterna, at a price to the public of $1.45 per share, less underwriting discounts and commissions.

Revenues of $4.9 and $16.5 million for the quarter and nine months ended December 31, 2020 increased by 13% and 21%, respectively, compared to the same periods in the prior year due to strong international growth Operating expenses of $2.1 and $7.4 million for the quarter and nine months ended December 31, 2020 both decreased by 31% compared to the prior year

Thousands of retailers nationwide support MDA’s fundraising campaign to transform the lives of people living with muscular dystrophy, ALS and related neuromuscular diseases throughout February and March.

Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of its innovative CellMag product line f

CyberMDX , a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced that the company has been named a Representative Vendor in the Gartner 2020 Market Guide for Medical Device Security Solutions.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has thus far raised a total of US $1.1 million under the terms of a Series F Preferred Stock Offering.

QUILT 3.032 study completes planned enrollment of BCG unresponsive non-muscle invasive bladder cancer CIS cohort with 59% probability of patients maintaining complete response for at least 12 months Over 87.5% of patients in this study have avoided a cystectomy to date

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda has been appointed to its Board of Directors, effective March 1, 2021. In addition, Ms. Miranda was appointed to the Board’s Compensation Committee.